There are plenty of good artificial intelligence (AI) stocks available to investors these days, and if you've got $1,000 to invest right now, you've likely thought about buying Micron Technology ...

AbbVie (NYSE: ABBV) was spun off from Abbott (NYSE: ABT) in 2013. That's an important fact to keep in mind when you look at AbbVie's Dividend King status. Technically, it hasn't increased its dividend ...

Space Exploration Technologies (NASDAQ: SPCX) took off like one of its Falcon 9 rockets in the immediate days following its initial public offering on June 12, 2026. That IPO was one for the record ...

Obviously, nobody owns a functioning crystal ball. So, take any predictions about someone else's future actions with a grain of salt. You can make educated guesses, however, based on a person's past ...

Over the last couple of years, Super Micro Computer (NASDAQ: SMCI) has dealt with some notable headwinds that have affected perceptions around the company.

Although Warren Buffett no longer heads Berkshire Hathaway, its stock trades and positions continue to attract plenty of attention.

— We have everything you need: full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock ...

Fitch Ratings affirmed the 'BBB-' LT Int. Scale (foreign curr.) credit rating of Apache on March 17, 2025. The outlook is stable.

A quantile analysis study identifies some green cryptocurrencies as better transmitters of volatility compared to green assets, challenging traditional assumptionsInvestors usually prefer ESG funds ...

Jefferies analyst Blayne Curtis has raised the price target for Advanced Micro Devices (NASDAQ: AMD) to $640.00, suggesting a potential upside of 18.59% from its recent trading price. The ...

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) is executing a 1-for-16 reverse stock split effective July 31, 2026. This corporate action aims to optimize market dynamics, enhance ...

In recent trading, shares of Omega Healthcare Investors, Inc. (Symbol: OHI) have crossed above the average analyst 12-month target price of $32.62, changing hands for $32.66/share.